Pages that link to "Q34770315"

The following pages link to SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder (Q34770315):

Displaying 39 items.

• European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (Q21260332) (← links)
• Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder (Q27319295) (← links)
• What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ). (Q30596479) (← links)
• Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate (Q33457863) (← links)
• Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder (Q34041476) (← links)
• Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (Q34661181) (← links)
• Serum matrix metalloproteinase-9 levels and severity of symptoms in boys with attention deficit hyperactivity disorder ADHD/hyperkinetic disorder HKD (Q34924426) (← links)
• L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children (Q34981500) (← links)
• Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks (Q35017175) (← links)
• Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder (Q35050238) (← links)
• Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder (Q35116217) (← links)
• Methylphenidate increases cigarette smoking in participants with ADHD. (Q35293009) (← links)
• Recent Advances in Imaging of Dopaminergic Neurons for Evaluation of Neuropsychiatric Disorders (Q35910290) (← links)
• Effects of zinc and ferritin levels on parent and teacher reported symptom scores in attention deficit hyperactivity disorder (Q36102608) (← links)
• Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma (Q36530958) (← links)
• Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial (Q36894571) (← links)
• Preparatory neural networks are impaired in adults with attention-deficit/hyperactivity disorder during the antisaccade task (Q37184515) (← links)
• Infantile parkinsonism-dystonia: a dopamine "transportopathy" (Q37209176) (← links)
• Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride (Q37318744) (← links)
• Differences at brain SPECT between depressed females with and without adult ADHD and healthy controls: etiological considerations (Q37365804) (← links)
• Association between phthalates and attention deficit disorder and learning disability in U.S. children, 6-15 years (Q37469972) (← links)
• Low blood zinc, iron, and other sociodemographic factors associated with behavior problems in preschoolers (Q37617700) (← links)
• Role of zinc in the pathogenesis of attention-deficit hyperactivity disorder: implications for research and treatment (Q37784201) (← links)
• A review of psychostimulant-induced neuroadaptation in developing animals (Q37879918) (← links)
• Applying imaging genetics to ADHD: the promises and the challenges (Q38200975) (← links)
• Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies (Q38300369) (← links)
• Circulating phthalates during critical illness in children are associated with long-term attention deficit: a study of a development and a validation cohort. (Q38398460) (← links)
• Adult ADHD and comorbid disorders: clinical implications of a dimensional approach (Q41495299) (← links)
• Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan (Q42326125) (← links)
• Striatal Presynaptic Dopamine in Schizophrenia, Part I: Meta-Analysis of Dopamine Active Transporter (DAT) Density (Q42413756) (← links)
• Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD. (Q43276213) (← links)
• DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD. (Q47927866) (← links)
• Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum (Q48766388) (← links)
• Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro (Q50761866) (← links)
• Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype. (Q51899756) (← links)
• Disorder-specific dysfunctions in patients with attention-deficit/hyperactivity disorder compared to patients with obsessive-compulsive disorder during interference inhibition and attention allocation (Q57650063) (← links)
• Overlaps and distinctions between attention deficit/hyperactivity disorder and autism spectrum disorder in young adulthood: Systematic review and guiding framework for EEG research (Q58118863) (← links)
• Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates (Q90366205) (← links)
• Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study (Q90395299) (← links)